Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels
The DOI matches its Crossref record.
Abstract
The relations of regional adipose tissue (AT) distribution measured by computed tomography (CT) to plasma insulin-glucose homeostasis and lipoprotein-lipid levels were studied in 58 obese and 29 lean control men. In the group of obese men, the visceral AT area measured by CT was positively correlated with fasting plasma triglyceride and insulin levels and with glucose and insulin areas under the curves measured during a 75-g oral glucose tolerance test. Visceral AT area was also negatively associated with plasma high-density lipoprotein (HDL) and HDL2 cholesterol levels. The relative accumulation of abdominal fat, estimated by the ratio of abdominal to femoral AT areas obtained by CT, was also a significant correlate of indices of carbohydrate metabolism and was the best univariate correlate of plasma lipoprotein levels. No significant associations were observed between the visceral AT area, the ratio of abdominal to femoral AT areas, and indices of carbohydrate and lipoprotein metabolism in the group of lean men. On the other hand, the subcutaneous abdominal AT area was a significant correlate of the glucose area under the curve in both groups of men, but this association was not independent from the percentage of total body fat. No relationship was observed between the femoral AT area and indices of carbohydrate metabolism in either lean or obese groups. In obese men, however, the femoral AT area was negatively correlated with plasma triglyceride concentration and positively correlated with plasma HDL and HDL2 cholesterol levels. Comparison between two subgroups of equally obese men showing either low or high levels of visceral AT and a group of lean men generally revealed that only obese men with high levels of visceral AT showed significant metabolic alterations compared with lean men. These results demonstrate that the amount of visceral AT and the ratio of abdominal to femoral AT measured by CT are important correlates of the alterations in carbohydrate and lipoprotein metabolism observed in obese men. In addition, our results suggest that obesity is required to observe significant associations between body fat distribution measured by CT and metabolic variables. Finally, we suggest that, in men, a high accumulation of femoral fat may be protective against the adverse effects of obesity, particularly abdominal obesity, on plasma lipoprotein levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
“However, metabolic studies conducted exclusively on non-smokers have confirmed the very significant relationship between abdominal adiposity and an atherogenic and diabetogenic metabolic risk profil”
BackgroundSelf-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
“In both men and women, we found that obese individuals with low levels of visceral adipose tissue had normal glucose tolerance compared with lean controls (115, 444).”
BackgroundSelf-citationKahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Pouliot, M.-C., Després, J.-P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., & Lupien, P. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90676-9 · Cited by 2,085
Self-citationHyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Self-citationShen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692
“Although the L4-L5 level is the most commonly used location for estimating VAT area (1, 3, 7, 9, 10, 15, 17, 25), we also examined models using other abdominal locations.”
BackgroundMethodAbdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk
Després, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., Rodés-Cabau, J., Bertrand, O. F., & Poirier, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.159228 · Cited by 1,589
The Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449
“Abdominal obesity is closely associated with increased insulin resistance, compensatory hyperinsulinemia, and increased risk of type 2 diabetes, independent of an individual’s total body fat content (62).”
BackgroundGrundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
Bastien, M., Poirier, P., Lemieux, I., & Després, J.-P. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.10.016 · Cited by 1,125
Self-citationde Koning, L., Merchant, A. T., Pogue, J., & Anand, S. S. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm026 · Cited by 1,073
Assessing Adiposity: A Scientific Statement From the American Heart Association
Cornier, M.-A., Després, J.-P., Davis, N., Grossniklaus, D. A., Klein, S., Lamarche, B., Lopez-Jimenez, F., Rao, G., St-Onge, M.-P., Towfighi, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318233bc6a · Cited by 945
Self-citationLemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.179 · Cited by 937
Self-citationVillareal, D. T., Apovian, C. M., Kushner, R. F., & Klein, S. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.5.923 · Cited by 880
Treatment of obesity: need to focus on high risk abdominally obese patients
Després, J.-P., Lemieux, I., & Prud'homme, D. (2001) · BMJ · doi:10.1136/bmj.322.7288.716 · Cited by 826
Self-citationHealth implications of obesity
Pi-Sunyer, F. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.6.1595s · Cited by 809
Hida, K., Wada, J., Eguchi, J., Zhang, H., Baba, M., Seida, A., Hashimoto, I., Okada, T., Yasuhara, A., Nakatsuka, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504703102 · Cited by 719
Freedman, D. S., Serdula, M. K., Srinivasan, S. R., & Berenson, G. S. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.2.308 · Cited by 682
Hadigan, C., Meigs, J. B., Corcoran, C., Rietschel, P., Piecuch, S., Basgoz, N., Davis, B., Sax, P., Stanley, T., Wilson, P. W. F., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/317541 · Cited by 680
Is visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651
Self-citationBody Composition, Visceral Fat, Leptin, and Insulin Resistance in Asian Indian Men1
Banerji, M. A., Faridi, N., Atluri, R., Chaiken, R. L., & Lebovitz, H. E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5371 · Cited by 598
Villareal, D. T., Apovian, C. M., Kushner, R. F., & Klein, S. (2005) · Obesity Research · doi:10.1038/oby.2005.228 · Cited by 579
Sex differences in the relation of visceral adipose tissue accumulation to total body fatness
Lemieux, S., Prud'homme, D., Bouchard, C., Tremblay, A., & Després, J. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.4.463 · Cited by 561
Self-citationWidén, E., Lehto, M., Kanninen, T., Walston, J., Shuldiner, A. R., & Groop, L. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330604 · Cited by 541
Estrogen: A master regulator of bioenergetic systems in the brain and body
Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534
The metabolic syndrome: is this diagnosis necessary?1,2
Reaven, G. M. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1237 · Cited by 524
Lemieux, S., Prud’homme, D., Bouchard, C., Tremblay, A., & Després, J. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.5.685 · Cited by 472
Self-citationMcLaughlin, T., Lamendola, C., Liu, A., & Abbasi, F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0615 · Cited by 468
Obesity, Inflammation, and Immune System in Osteoarthritis
Nedunchezhiyan, U., Varughese, I., Sun, A. R., Wu, X., Crawford, R., & Prasadam, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907750 · Cited by 466
Smith, J. C., Bennett, S., Evans, L. M., Kynaston, H. G., Parmar, M., Mason, M. D., Cockcroft, J. R., Scanlon, M. F., & Davies, J. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7851 · Cited by 458
Cnop, M., Landchild, M. J., Vidal, J., Havel, P. J., Knowles, N. G., Carr, D. R., Wang, F., Hull, R. L., Boyko, E. J., Retzlaff, B. M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1005 · Cited by 432
Study, F. T. H. A., Snijder, M. B., Visser, M., Dekker, J. M., Goodpaster, B. H., Harris, T. B., Kritchevsky, S. B., De Rekeneire, N., Kanaya, A. M., Newman, A. B., et al. (2005) · Diabetologia · doi:10.1007/s00125-004-1637-7 · Cited by 412
Kip, K. E., Marroquin, O. C., Kelley, D. E., Johnson, B. D., Kelsey, S. F., Shaw, L. J., Rogers, W. J., & Reis, S. E. (2004) · Circulation · doi:10.1161/01.cir.0000115514.44135.a8 · Cited by 412
Disorders of glucose metabolism in sleep apnea
Punjabi, N. M., & Polotsky, V. Y. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00695.2005 · Cited by 375
Scha¨fer, H., Pauleit, D., Sudhop, T., Gouni-Berthold, I., Ewig, S., & Berthold, H. K. (2002) · Chest · doi:10.1378/chest.122.3.829 · Cited by 360
Visceral adipose tissue: relations between single-slice areas and total volume
Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.271 · Cited by 350
Snijder, M. B., Zimmet, P. Z., Visser, M., Dekker, J. M., Seidell, J. C., & Shaw, J. E. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802567 · Cited by 340
Health consequences of visceral obesity
Després, J.-P. (2001) · Annals of Medicine · doi:10.3109/07853890108995963 · Cited by 334
Self-citationThe complex role of adipokines in obesity, inflammation, and autoimmunity
Taylor, E. B. (2021) · Clinical Science · doi:10.1042/cs20200895 · Cited by 330
Point: Visceral Adiposity Is Causally Related to Insulin Resistance
Lebovitz, H. E., & Banerji, M. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2322 · Cited by 328
Cook, S., Auinger, P., Li, C., & Ford, E. S. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.06.004 · Cited by 325
Metabolic Syndrome: Past, Present and Future
Lemieux, I., & Després, J.-P. (2020) · Nutrients · doi:10.3390/nu12113501 · Cited by 309
Self-citationInsulin-like growth factor-1 deficiency and metabolic syndrome
Aguirre, G. A., De Ita, J. R., de la Garza, R. G., & Castilla-Cortazar, I. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0762-z · Cited by 295
Caprio, S., Hyman, L., McCarthy, S., Lange, R., Bronson, M., & Tamborlane, W. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.1.12 · Cited by 288
Nieves, D. J., Cnop, M., Retzlaff, B., Walden, C. E., Brunzell, J. D., Knopp, R. H., & Kahn, S. E. (2003) · Diabetes · doi:10.2337/diabetes.52.1.172 · Cited by 281
Després, J.-P., & Lamarche, B. (1993) · Nutrition Research Reviews · doi:10.1079/nrr19930010 · Cited by 277
Self-citationAbdominal Obesity and the Metabolic Syndrome
Després, J.-P., Lemieux, I., & Alméras, N. (2007) · Endocrine Updates · doi:10.1007/978-0-387-32164-6_8 · Cited by 277
Self-citationn−3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik
Dewailly, E., Blanchet, C., Lemieux, S., Sauvé, L., Gingras, S., Ayotte, P., & Holub, B. J. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.464 · Cited by 276
Pericardial fat accumulation in men as a risk factor for coronary artery disease
Taguchi, R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00709-7 · Cited by 275
AGA technical review on obesity
Klein, S., Wadden, T., & Sugerman, H. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35514 · Cited by 274
Stanhope, K. L., & Havel, P. J. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f2b24a · Cited by 269
Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function
Sironi, A. M., Gastaldelli, A., Mari, A., Ciociaro, D., Postano, V., Buzzigoli, E., Ghione, S., Turchi, S., Lombardi, M., & Ferrannini, E. (2004) · Hypertension · doi:10.1161/01.hyp.0000137982.10191.0a · Cited by 268
Relation of muscle mass and fat mass to cardiovascular disease mortality
Srikanthan, P., Horwich, T. B., & Tseng, C. H. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.01.033 · Cited by 260
Visceral fat and metabolic inflammation: the portal theory revisited
Item, F., & Konrad, D. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01035.x · Cited by 265
The Insulin Resistance—Dyslipidemic Syndrome of Visceral Obesity: Effect on Patients' Risk
Després, J. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00683.x · Cited by 261
Self-citationVisceral fat and liver fat are independent predictors of metabolic risk factors in men
Nguyen-Duy, T.-B., Nichaman, M. Z., Church, T. S., Blair, S. N., & Ross, R. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00442.2002 · Cited by 261
Genetic Architecture of Insulin Resistance in the Mouse
Parks, B. W., Sallam, T., Mehrabian, M., Psychogios, N., Hui, S. T., Norheim, F., Castellani, L. W., Rau, C. D., Pan, C., Phun, J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.002 · Cited by 249
“We performed association with common traits associated with IR, including central obesity and plasma triglyceride levels (Pouliot et al., 1992).”
BackgroundMethodInfluentialStrasser, B., Siebert, U., & Schobersberger, W. (2010) · Sports Medicine · doi:10.2165/11531380-000000000-00000 · Cited by 258
Hill, J. O., Sidney, S., Lewis, C. E., Tolan, K., Scherzinger, A. L., & Stamm, E. R. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.3.381 · Cited by 257
The case of visceral fat: argument for the defense
Klein, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422028 · Cited by 206
Després, J.-P. (2006) · European Heart Journal Supplements · doi:10.1093/eurheartj/sul002 · Cited by 205
Self-citationIntermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans
Sachs, S., Zarini, S., Kahn, D. E., Harrison, K. A., Perreault, L., Phang, T., Newsom, S. A., Strauss, A., Kerege, A., Schoen, J. A., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00243.2018 · Cited by 192
Pathogenesis and pathophysiology of the cardiometabolic syndrome
Kirk, E. P., & Klein, S. (2009) · The Journal of Clinical Hypertension · doi:10.1111/j.1559-4572.2009.00054.x · Cited by 195
Cohen, P. G. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1169 · Cited by 172
Effect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men
Purnell, J. Q. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.977 · Cited by 161
“More specifically, accumulation of intraabdominal, or visceral, fat has been consistently shown to correlate with a number of the metabolic abnormalities associated with an increased risk for CAD, including insulin resistance and dyslipidemia (1, 3, 34 , 35).”
BackgroundRegulation of Lipogenesis by Glucocorticoids and Insulin in Human Adipose Tissue
Gathercole, L. L., Morgan, S. A., Bujalska, I. J., Hauton, D., Stewart, P. M., & Tomlinson, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026223 · Cited by 150
Ioachimescu, A. G., Brennan, D. M., Hoar, B. M., & Hoogwerf, B. J. (2010) · Obesity · doi:10.1038/oby.2009.453 · Cited by 147
Exercise Training Prevents Regain of Visceral Fat for 1 Year Following Weight Loss
Hunter, G. R., Brock, D. W., Byrne, N. M., Chandler‐Laney, P. C., Del Corral, P., & Gower, B. A. (2010) · Obesity · doi:10.1038/oby.2009.316 · Cited by 136
Reaven, G. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.017 · Cited by 135
Respiratory complications of obesity
Jubber, A. S. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.00166.x · Cited by 124
Systemic and regional free fatty acid metabolism in type 2 diabetes
Basu, A., Basu, R., Shah, P., Vella, A., Rizza, R. A., & Jensen, M. D. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e1000 · Cited by 123
Grunfeld, C., Rimland, D., Gibert, C. L., Powderly, W. G., Sidney, S., Shlipak, M. G., Bacchetti, P., Scherzer, R., Haffner, S. M., & Heymsfield, S. B. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31814b94e2 · Cited by 114
Saponaro, C., Sabatini, S., Gaggini, M., Carli, F., Rosso, C., Positano, V., Armandi, A., Caviglia, G. P., Faletti, R., Bugianesi, E., et al. (2022) · Liver International · doi:10.1111/liv.15377 · Cited by 116
Tchernof, A., Labrie, F., Bélanger, A., Prud'homme, D., Bouchard, C., Tremblay, A., Nadeau, A., & Després, J.-P. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00125-1 · Cited by 107
Self-citationEchocardiographic Abnormalities in Normotensive Obese Patients: Relationship with Visceral Fat
Morricone, L., Malavazos, A. E., Coman, C., Donati, C., Hassan, T., & Caviezel, F. (2002) · Obesity Research · doi:10.1038/oby.2002.67 · Cited by 104
Regional Fat Deposition as a Factor in FFA Metabolism
Votruba, S. B., & Jensen, M. D. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093754 · Cited by 72
METABOLIC COMPLICATIONS OF OBESITY
Sheehan, M. T., & Jensen, M. D. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70226-1 · Cited by 68
Boivin, A., & Deshaies, Y. (1995) · Metabolism · doi:10.1016/0026-0495(95)90072-1 · Cited by 45
Nakanishi, N., Takatorige, T., & Suzuki, K. (2004) · Diabetologia · doi:10.1007/s00125-004-1528-y · Cited by 44
“The central pattern of weight distribution (as indicated by an increased WHR) is associated with a higher frequency of insulin resistance than the peripheral pattern of distribution, and individuals with the central distribution pattern are more likely to have glucose intolerance and hyperinsulinaemia resulting from i…”
Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women
Chmouliovsky, L., Habicht, F., James, R. W., Lehmann, T., Campana, A., & Golay, A. (1999) · Maturitas · doi:10.1016/s0378-5122(99)00037-7 · Cited by 36
Maekawa, F., Fujiwara, K., Toriya, M., Maejima, Y., Nishio, T., Toyoda, Y., Nohara, K., Yashiro, T., & Yada, T. (2013) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2013.00007 · Cited by 19
Dinas, P. C., Markati, A. S., & Carrillo, A. E. (2014) · ISRN Physiology · doi:10.1155/2014/964627 · Cited by 19
Metadata
- Authors
- Pouliot, M.-C., Després, J.-P., Nadeau, A., Moorjani, S., Prud'Homme, D., Lupien, P. J., Tremblay, A., & Bouchard, C.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1992-07-01
- Volume
- 41
- Issue
- 7
- Pages
- 826-834
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2161914374
- Cited by
- 635
- References
- 0
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.